M&A
Reckitt Benckiser confirms bidding for Merck & Co's consumer health business
29 Apr 2014
British consumer goods company Reckitt Benckiser has emerged as a front runner in the auction, although Bayer AG, Novartis, and Procter & Gamble Co are also in the race
Siemens barges into Alstom - GE deal with asset-swap offer
By By Ravi Kunder | 28 Apr 2014
Siemens proposes to give some of its high-speed train and locomotive businesses plus cash to Alstom in exchange for its power business, which GE was close to buying for $13 billion. By Ravi Kunder
Pfizer confirms AstraZeneca's rejection; to explore options
28 Apr 2014
US drugs giant Pfizer today confirmed that it had made a $98.67 billion (£58.73 billion) takeover offer for AstraZeneca, which was rejected by the UK-based company
Forest Labs to buy GI specialist Furiex in $1.46-bn deal
28 Apr 2014
Forest, which itself is in the process of being acquired by Actavis Plc for $25 billion, said that Actavis supported the deal
Bayer mulls selling plastics unit worth $10.8 bn
28 Apr 2014
With sales of €11.5 billion, Bayer MaterialScience is one of the world’s largest producers of polymers and high-performance plastics.
Wilmar International tables $1.18-bn bid for Australian food firm Goodman Fielder
28 Apr 2014
Australian food company, Goodman Fielder, today rejected an unsolicited $1.18 billion takeover bid from Singapore's agribusiness group Wilmar International Limited, saying the offer undervalued the company.
EID Parry acquires Bayer’s nutraceuticals arm Alimtec in Chlie
26 Apr 2014
Alimtec makes Haematococcus pluvialis biomass, a cultured micro-algae, which is a rich natural source of Astaxanthin for human use
EID Parry acquires Bayer’s nutraceuticals arm Alimtec in Chlie
26 Apr 2014
Alimtec makes Haematococcus pluvialis biomass, a cultured micro-algae, which is a rich natural source of Astaxanthin for human use
EID Parry acquires Bayer’s nutraceuticals arm Alimtec in Chlie
26 Apr 2014
Alimtec makes Haematococcus pluvialis biomass, a cultured micro-algae, which is a rich natural source of Astaxanthin for human use
Omnicom-Publicis 35-bn mega-merger hits roadblock
26 Apr 2014
The $35-billion trans-Atlantic mega-merger between Omnicom Group and France’s Publicis Groupe SA to create the world's largest advertising business has hit roadblocks over disagreements on the terms of the deal
Nokia completes deal with Microsoft sans Chennai plant
25 Apr 2014
Nokia’s Chennai plant will operate as a contract manufacturer for Microsoft till Indian tax disputes are resolved
JSPL takes over NRE Coke’s Australian operations
25 Apr 2014
Navin Jindal-controlled JSPL recently acquired a controlling stake and management control of WCL, formerly Gujarat NRE Coking Coal Ltd
NTT DoCoMo to exit Tata Tele joint venture
25 Apr 2014
Japan's NTT DoCoMo Inc is looking to unload its 26.5 per cent stake in loss-making Indian mobile phone joint venture Tata Teleservices Ltd and exit the country amidst mounting losses and tough price competition
Britain’s Shire Plc recently rejected Allergan’s takeover approach: report
25 Apr 2014
Shire, the UK's third-biggest drug maker with a market cap of $33 billion, is itself an aggressive acquirer, having made 15 acquisitions since 2000